XML 66 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock Award Plans and Stock-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2017
Stock-Based Compensation Recognized

The following table summarizes stock-based compensation expense by financial statement line item in the Company’s consolidated statements of operations for the fiscal years ended March 31, 2017, 2016 and 2015:

 

 

 

Fiscal Years Ended March 31,

 

 

 

 

2017

 

 

 

2016

 

 

 

2015

 

 

 

(in $000's)

 

Cost of product revenue

 

$

1,061

 

 

$

895

 

 

$

665

 

Research and development

 

 

6,050

 

 

 

3,950

 

 

 

3,205

 

Selling, general and administrative

 

 

25,755

 

 

 

24,208

 

 

 

12,650

 

 

 

$

32,866

 

 

$

29,053

 

 

$

16,520

 

 

Components of Stock-Based Compensation

The components of stock-based compensation for the fiscal years ended March 31, 2017, 2016 and 2015 were as follows:

 

 

 

Fiscal Years Ended March 31,

 

 

 

 

2017

 

 

 

2016

 

 

 

2015

 

 

 

(in $000's)

 

Restricted stock units

 

$

26,570

 

 

$

23,708

 

 

$

13,539

 

Stock options

 

 

5,829

 

 

 

4,866

 

 

 

2,708

 

Employee stock purchase plan

 

 

467

 

 

 

479

 

 

 

273

 

 

 

$

32,866

 

 

$

29,053

 

 

$

16,520

 

 

Summary of Stock Option Activity

The following table summarized stock option activity for the year ended March 31, 2017:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

Options

 

 

Exercise

 

 

Contractual

 

 

Value

 

 

 

(in thousands)

 

 

Price

 

 

Term (years)

 

 

(in thousands)

 

Outstanding at beginning of period

 

 

2,244

 

 

$

20.55

 

 

 

5.19

 

 

 

 

 

Granted

 

 

180

 

 

 

106.10

 

 

 

 

 

 

 

 

 

Exercised

 

 

(755

)

 

 

14.12

 

 

 

 

 

 

 

 

 

Cancelled and expired

 

 

(23

)

 

 

73.50

 

 

 

 

 

 

 

 

 

Outstanding at end of period

 

 

1,646

 

 

$

32.09

 

 

 

5.46

 

 

$

153,254

 

Exercisable at end of period

 

 

1,156

 

 

$

18.26

 

 

 

4.36

 

 

$

123,592

 

Options vested and expected to vest at end of period

 

 

1,594

 

 

$

31.06

 

 

 

5.37

 

 

$

150,056

 

 

Summary of Weighted Average Grant-Date Fair Values And Weighted Average Assumptions Used to Calculate Fair Value of Options Granted

The weighted average grant-date fair values and weighted average assumptions used in the calculation of fair value of options granted during the fiscal years ended March 31, 2017, 2016 and 2015 was as follows:

 

 

 

Fiscal Years Ended March 31,

 

 

 

 

2017

 

 

 

2016

 

 

 

2015

 

Valuation assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average grant-date fair value

 

$

42.40

 

 

$

29.57

 

 

$

9.29

 

Risk-free interest rate

 

 

1.41

%

 

 

1.55

%

 

 

1.60

%

Expected option life (years)

 

 

4.14

 

 

 

4.15

 

 

 

4.19

 

Expected volatility

 

 

48.9

%

 

 

49.7

%

 

 

49.3

%

 

Restricted Stock Units  
Summary of Restricted Stock Units Activity

The following table summarizes restricted stock unit activity for the fiscal year ended March 31, 2017:

 

 

 

Number of

Shares

 

 

Weighted

Average

Grant Date

Fair Value

 

 

 

(in thousands)

 

 

(per share)

 

Restricted stock units at beginning of period

 

 

1,263

 

 

$

57.95

 

Granted

 

 

366

 

 

$

97.43

 

Vested

 

 

(502

)

 

$

35.05

 

Forfeited

 

 

(71

)

 

$

91.39

 

Restricted stock units at end of period

 

 

1,056

 

 

$

80.50

 

 

Monte Carlo Simulation Model to Estimate Grant-Date Fair Value of Restricted Stock Units

The table below sets forth the assumptions used to value the market-based awards and the estimated grant-date fair value:

 

 

 

June 2015

Awards

 

 

November 2016

Awards

 

Risk-free interest rate

 

 

1.10

%

 

 

0.90

%

Dividend yield

 

 

0

%

 

 

0

%

Remaining performance period (years)

 

 

1.21

 

 

 

1.21

 

Expected volatility

 

 

47.2

%

 

 

50.6

%

Estimated grant date fair value (per share)

 

$

107.10

 

 

$

62.55

 

Target performance (number of shares)

 

 

107,660

 

 

 

41,526